123 related articles for article (PubMed ID: 26344721)
41. Recognition of ovarian cancer antigen CA125 by murine monoclonal antibody produced by immunization of lung cancer cells.
Matsuoka Y; Nakashima T; Endo K; Yoshida T; Kunimatsu M; Sakahara H; Koizumi M; Nakagawa T; Yamaguchi N; Torizuka K
Cancer Res; 1987 Dec; 47(23):6335-40. PubMed ID: 3315184
[TBL] [Abstract][Full Text] [Related]
42. Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.
Tran L; Mattsson JS; Nodin B; Jönsson P; Planck M; Jirström K; Botling J; Micke P; Brunnström H
Appl Immunohistochem Mol Morphol; 2016 Oct; 24(9):648-659. PubMed ID: 26447895
[TBL] [Abstract][Full Text] [Related]
43. Evidence for circulating cancer stem-like cells and epithelial-mesenchymal transition phenotype in the pleurospheres derived from lung adenocarcinoma using liquid biopsy.
Mirza S; Jain N; Rawal R
Tumour Biol; 2017 Mar; 39(3):1010428317695915. PubMed ID: 28347243
[TBL] [Abstract][Full Text] [Related]
44. Proteomic analysis of proteins related to prognosis of lung adenocarcinoma.
Okayama A; Miyagi Y; Oshita F; Nishi M; Nakamura Y; Nagashima Y; Akimoto K; Ryo A; Hirano H
J Proteome Res; 2014 Nov; 13(11):4686-94. PubMed ID: 25004236
[TBL] [Abstract][Full Text] [Related]
45. Isolation and characterization of human lung cancer antigens by serological screening with autologous antibodies.
Hanafusa T; Mohamed AE; Kitaoka K; Ohue Y; Nakayama E; Ono T
Cancer Lett; 2011 Feb; 301(1):57-62. PubMed ID: 21094583
[TBL] [Abstract][Full Text] [Related]
46. TTF-1 positivity in metastatic colorectal carcinoma: a diagnostic pitfall in transbronchial biopsy.
Mourra N; Bengrine-Lefevre L
Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):574-6. PubMed ID: 20733478
[No Abstract] [Full Text] [Related]
47. Humoral immune responses of lung cancer patients against the Transmembrane Phosphatase with TEnsin homology (TPTE).
Kuemmel A; Simon P; Breitkreuz A; Röhlig J; Luxemburger U; Elsäßer A; Schmidt LH; Sebastian M; Sahin U; Türeci Ö; Buhl R
Lung Cancer; 2015 Nov; 90(2):334-41. PubMed ID: 26350112
[TBL] [Abstract][Full Text] [Related]
48. Immunoperoxidase staining for Ia-like antigens in paraffin-embedded tissues from human melanoma and lung carcinoma.
Wilson BS; Herzig MA; Lloyd RV
Am J Pathol; 1984 Apr; 115(1):102-8. PubMed ID: 6369992
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer.
Li P; Shi JX; Xing MT; Dai LP; Li JT; Zhang JY
Tumour Biol; 2017 Oct; 39(10):1010428317711662. PubMed ID: 29022480
[TBL] [Abstract][Full Text] [Related]
50. Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion.
Han HS; Yun J; Lim SN; Han JH; Lee KH; Kim ST; Kang MH; Son SM; Lee YM; Choi SY; Yun SJ; Kim WJ; Lee OJ
Int J Cancer; 2013 Aug; 133(3):645-52. PubMed ID: 23354517
[TBL] [Abstract][Full Text] [Related]
51. Calnexin as a dual-role biomarker: antibody-based diagnosis and therapeutic targeting in lung cancer.
Lim S; Ha Y; Lee B; Shin J; Rhim T
BMB Rep; 2024 Mar; 57(3):155-160. PubMed ID: 38303563
[TBL] [Abstract][Full Text] [Related]
52. Detection of tumor-associated antigens in the sera of lung cancer patients by three monoclonal antibodies.
Hirota M; Fukushima K; Terasaki PI; Terashita GY; Galton J; Kawahara M
Cancer Res; 1985 Dec; 45(12 Pt 1):6453-6. PubMed ID: 2998602
[TBL] [Abstract][Full Text] [Related]
53. A circulating non-coding RNA panel as an early detection predictor of non-small cell lung cancer.
Peng H; Wang J; Li J; Zhao M; Huang SK; Gu YY; Li Y; Sun XJ; Yang L; Luo Q; Huang CZ
Life Sci; 2016 Apr; 151():235-242. PubMed ID: 26946307
[TBL] [Abstract][Full Text] [Related]
54. Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer.
Korkmaz ET; Koksal D; Aksu F; Dikmen ZG; Icen D; Maden E; Onder S; Akbiyik F; Emri S
Clin Biochem; 2018 Aug; 58():15-19. PubMed ID: 29729229
[TBL] [Abstract][Full Text] [Related]
55. Identification and characterization of monoclonal antibodies against GP73 for use as a potential biomarker in liver cancer screening and diagnosis.
Zhang Y; Xi Y; Fang J; Luo S; Wilson JJ; Huang RP
J Immunoassay Immunochem; 2016; 37(4):390-406. PubMed ID: 27088654
[TBL] [Abstract][Full Text] [Related]
56. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer.
Jiang ZF; Wang M; Xu JL
Life Sci; 2018 Feb; 194():1-6. PubMed ID: 29247745
[TBL] [Abstract][Full Text] [Related]
57. Anti-Podocalyxin Monoclonal Antibody 47-mG
Yamada S; Itai S; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2018 Apr; 37(2):91-94. PubMed ID: 29649375
[TBL] [Abstract][Full Text] [Related]
58. Immunocytochemical staining for stratifin and OCIAD2 in bronchial washing specimens increases sensitivity for diagnosis of lung cancer.
Itoguchi N; Nakagawa T; Murata Y; Li D; Shiba-Ishii A; Minami Y; Noguchi M
Cytopathology; 2015 Dec; 26(6):354-61. PubMed ID: 25376185
[TBL] [Abstract][Full Text] [Related]
59. Antigens associated with a human lung adenocarcinoma defined by monoclonal antibodies.
Varki NM; Reisfeld RA; Walker LE
Cancer Res; 1984 Feb; 44(2):681-7. PubMed ID: 6362852
[TBL] [Abstract][Full Text] [Related]
60. Immunohistochemical expression of estrogen receptor in adenocarcinomas of the lung: the antibody factor.
Gomez-Fernandez C; Mejias A; Walker G; Nadji M
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):137-41. PubMed ID: 19875957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
